- Home
- TENX vs SSKN Comparison
TENX vs SSKN Comparison
Compare TENX & SSKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TENX
- SSKN
- Stock Information
- Founded
- TENX 1967
- SSKN 1989
- Country
- TENX United States
- SSKN United States
- Employees
- TENX N/A
- SSKN N/A
- Industry
- TENX Biotechnology: Pharmaceutical Preparations
- SSKN Medical/Dental Instruments
- Sector
- TENX Health Care
- SSKN Health Care
- Exchange
- TENX Nasdaq
- SSKN Nasdaq
- Market Cap
- TENX 19.5M
- SSKN 12.5M
- IPO Year
- TENX N/A
- SSKN 2005
- Fundamental
- Price
- TENX $5.61
- SSKN $2.89
- Analyst Decision
- TENX Strong Buy
- SSKN
- Analyst Count
- TENX 4
- SSKN 0
- Target Price
- TENX $20.67
- SSKN N/A
- AVG Volume (30 Days)
- TENX 67.9K
- SSKN 8.1K
- Earning Date
- TENX 11-13-2024
- SSKN 11-13-2024
- Dividend Yield
- TENX N/A
- SSKN N/A
- EPS Growth
- TENX N/A
- SSKN N/A
- EPS
- TENX N/A
- SSKN N/A
- Revenue
- TENX N/A
- SSKN $32,674,999.00
- Revenue This Year
- TENX N/A
- SSKN $0.94
- Revenue Next Year
- TENX N/A
- SSKN $11.30
- P/E Ratio
- TENX N/A
- SSKN N/A
- Revenue Growth
- TENX N/A
- SSKN N/A
- 52 Week Low
- TENX $2.77
- SSKN $2.51
- 52 Week High
- TENX $27.36
- SSKN $6.50
- Technical
- Relative Strength Index (RSI)
- TENX 54.30
- SSKN 42.17
- Support Level
- TENX $5.70
- SSKN $2.96
- Resistance Level
- TENX $6.01
- SSKN $3.15
- Average True Range (ATR)
- TENX 0.47
- SSKN 0.12
- MACD
- TENX -0.08
- SSKN -0.01
- Stochastic Oscillator
- TENX 12.15
- SSKN 9.09
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.
About SSKN Strata Skin Sciences Inc.
Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders. Its primary products include the XTRAC excimer laser and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its operating segment includes Dermatology Recurring Procedures which is the key revenue driver and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. Its Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Geographically, it derives a majority of revenue from the United states.